KPTI - Karyopharm Therapeutics Inc
IEX Last Trade
0.7593
-0.012 -1.515%
Share volume: 481,269
Last Updated: Fri 30 Aug 2024 09:53:18 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$0.77
-0.01
-1.49%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-04 | 2022-11-03 | 2023-02-17 | 2023-05-04 | 2023-08-02 | 2023-11-02 | 2024-02-29 | 2024-05-08 | |
| Total revenue | 39.679 M | 36.145 M | 33.580 M | 38.698 M | 37.579 M | 36.009 M | 33.747 M | 33.126 M | |
| Cost of revenue | 939.000 K | 980.000 K | 1.868 M | 1.351 M | 1.194 M | 911.000 K | 1.486 M | 1.911 M | |
| Gross profit | 38.740 M | 35.165 M | 31.712 M | 37.347 M | 36.385 M | 35.098 M | 32.261 M | 31.215 M | |
| -9.23% | -9.82% | 17.77% | -2.58% | -3.54% | -8.08% | -3.24% | |||
| Operating expenses | 81.648 M | 66.004 M | 65.581 M | 68.246 M | 65.958 M | 66.358 M | 70.069 M | 64.974 M | |
| Selling general and admin | 37.339 M | 34.645 M | 34.649 M | 35.907 M | 34.481 M | 30.805 M | 30.688 M | 29.549 M | |
| Research and development | 44.309 M | 31.359 M | 30.932 M | 32.339 M | 31.477 M | 35.553 M | 39.381 M | 35.425 M | |
| Total expenses | 82.587 M | 66.984 M | 67.449 M | 69.597 M | 67.152 M | 67.269 M | 71.555 M | 66.885 M | |
| -18.89% | 0.69% | 3.18% | -3.51% | 0.17% | 6.37% | -6.53% | |||
| Operating income | -42.908 M | -30.839 M | -33.869 M | -30.899 M | -29.573 M | -31.260 M | -37.808 M | -33.759 M | |
| Ebit | -42.908 M | -30.839 M | -33.869 M | -30.899 M | -29.573 M | -31.260 M | -37.808 M | -33.759 M | |
| Pretax income | -48.941 M | -36.279 M | -38.433 M | -34.072 M | -32.503 M | -34.494 M | -41.707 M | -37.291 M | |
| -25.87% | 5.94% | -11.35% | -4.60% | 6.13% | 20.91% | -10.59% | |||
| Income tax | 121.000 K | 45.000 K | 73.000 K | 54.000 K | 127.000 K | 12.000 K | 130.000 K | 71.000 K | |
| Net income basic | -49.062 M | -36.324 M | -38.506 M | -34.126 M | -32.630 M | -34.506 M | -41.837 M | -37.362 M | |
| 25.96% | -6.01% | 11.37% | 4.38% | -5.75% | -21.25% | 10.70% | |||
| Net income | -49.062 M | -36.324 M | -38.506 M | -34.126 M | -32.630 M | -34.506 M | -41.837 M | -37.362 M | |
| 25.96% | -6.01% | 11.37% | 4.38% | -5.75% | -21.25% | 10.70% |